litlas
ログインアカウント作成

Peter Reichardt

1996–2024 年に発表

124
論文数
29,911
被引用数
83
h 指数
121
i10 指数

被引用数

Peter Reichardt の年別被引用数1926 年: 被引用 1 件1960 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 4 件1999 年: 被引用 13 件2000 年: 被引用 7 件2001 年: 被引用 22 件2002 年: 被引用 12 件2003 年: 被引用 16 件2004 年: 被引用 25 件2005 年: 被引用 47 件2006 年: 被引用 81 件2007 年: 被引用 103 件2008 年: 被引用 111 件2009 年: 被引用 142 件2010 年: 被引用 139 件2011 年: 被引用 132 件2012 年: 被引用 132 件2013 年: 被引用 130 件2014 年: 被引用 170 件2015 年: 被引用 164 件2016 年: 被引用 162 件2017 年: 被引用 183 件2018 年: 被引用 178 件2019 年: 被引用 654 件2020 年: 被引用 823 件2021 年: 被引用 846 件2022 年: 被引用 808 件2023 年: 被引用 584 件2024 年: 被引用 972 件2025 年: 被引用 373 件2026 年: 被引用 10 件1927〜1959 年は被引用が無いため表示していません1961〜1991 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,705 件、この内訳の 18.8%中国: 引用元論文 999 件、この内訳の 11%ドイツ: 引用元論文 766 件、この内訳の 8.4%イタリア: 引用元論文 643 件、この内訳の 7.1%イギリス: 引用元論文 579 件、この内訳の 6.4%フランス: 引用元論文 560 件、この内訳の 6.2%オランダ: 引用元論文 407 件、この内訳の 4.5%スペイン: 引用元論文 313 件、この内訳の 3.5%日本: 引用元論文 313 件、この内訳の 3.4%カナダ: 引用元論文 236 件、この内訳の 2.6%ベルギー: 引用元論文 214 件、この内訳の 2.4%スイス: 引用元論文 209 件、この内訳の 2.3%
0%18.8%その他 23.4%

機関

分野

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology11.6%
  • Engineering3.5%
  • Immunology and Microbiology3.5%
  • Materials Science2.4%
  • Neuroscience1.9%
  • その他2.2%

トピック

  • Sarcoma Diagnosis and Treatment10.8%
  • Gastrointestinal Tumor Research and Treatment6.3%
  • Gastric Cancer Management and Outcomes4%
  • Bone Tumor Diagnosis and Treatments3.1%
  • Gastrointestinal disorders and treatments2.3%
  • Vascular Tumors and Angiosarcomas1.9%
  • その他71.6%

共著者

全論文

検索で開く
  1. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    著者: Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Stéphanie Bolle, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Bernadette Brennan, Thomas Brodowicz, Angela Buonadonna, E. De Álava, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, Franca Fagioli, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, F. Gouin, Giovanni Grignani, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 被引用: 989

  2. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

    著者: Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales‐Barrera, Aude Fléchon, Şeyda Gündüz, Yohann Loriot, Alejo Rodríguez‐Vida, Ronac Mamtani, Evan Y. Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, D. Cascallar, Mirta Varela, Mauricio Fernández Lazzaro, Diego Kaen, Gabriela Gatica, David Hugo Flores, Agustín Falco, Matias Molina, F. Van Aelst, Christof Vulsteke, Brieuc Sautois, Jean‐Pascal Machiels, Denis Schallier, Leandro Brust, Liane Rapatoni, Sérgio Jobim Azevedo, GISELE LOPES MARINHO, João Paulo Holanda Soares, Carlos Dzik, Jamile Almeida Silva, André P. Fay, Joel Gingerich, Yves Fradet, Cristiano Ferrario, Kylea Potvin, Marie Vanhuyse, Mahmoud Abdelsalam, Susanna Cheng, Christian Caglevic, Felipe Reyes, José Luis Leal, Francisco Francisco, Carolina Ibáñez, Florence Joly, Brigitte Laguerre, Sylvain Ladoire, Aude Fléchon, Delphine Topart, Olivier Huillard, Stéphane Oudard, Marine Gross‐Goupil, Stéphane Culine, Yohann Loriot, Gwénaëlle Gravis, Peter Reichardt, Margitta Retz, Jan Herden, David G. Pfister, Carsten Ohlman, Michael Stöeckle, Manfred P. Wirth, Anja Lorch, Guenter Niegisch, Peter J. Goebell, Martin Boegemann, Axel S. Merseburger, Georgios Gakis, Jens Bedke, Andreas Neisius, Christian A. Thomas, Thomas Hoefner, András Telekes, Judit Kósa, János Révész, Gyorgy Bodoky, Tibor Csőszi, András Csejtei, Lajos Géczi, Ágnes Ruzsa, Zsuzsanna Kolonics, József Erfán, Ray McDermott, Richard Bambury, Avishay Sella, Stephen Jay Frank, Daniel Kejzman, Olesya Goldman, Eli Rosenbaum, Avivit Peer, Raanan Berger ほか 158 名 - The Lancet Oncology 2021 被引用: 648

  3. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    著者: Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina - European Journal of Cancer 2019 被引用: 726

  4. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Paolo G. Casali, N. Abecassis, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 1,621

  5. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: Sandra J. Strauss, Anna Maria Frezza, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Stéphanie Bolle, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Bernadette Brennan, Thomas Brodowicz, Angela Buonadonna, E. de Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, Franca Fagioli, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Nathalie Gaspar, Silvia Gasperoni, Hans Gelderblom, F. Gouin, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, A. López Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Ruth Ladenstein, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 被引用: 455

  6. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

    著者: Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T.A. van der Graaf, Breelyn A. Wilky, Richard F. Riedel, Allison Lim, L. Mary Smith, Stephanie Moody, Steven Attia, Sant P. Chawla, Gina Z. D’Amato, Noah Federman, Priscilla Merriam, Brian A. Van Tine, Bruno Vincenzi, Charlotte Benson, Nam Q. Bui, Rashmi Chugh, Gabriel Tinoco, John A. Charlson, Palma Dileo, Lee Hartner, Lore Lapeire, F Mazzeo, Emanuela Palmerini, Peter Reichardt, Silvia Stacchiotti, Howard H. Bailey, Melissa Burgess, Gregory M. Coté, Lara E. Davis, Hari A. Deshpande, Hans Gelderblom, Giovanni Grignani, Elizabeth T. Loggers, Tony Philip, Joseph G. Pressey, Shivaani Kummar, Bernd Kasper - New England Journal of Medicine 2023 被引用: 242

  7. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Paolo G. Casali, Jean‐Yves Blay, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Thomas Brodowicz, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, F. Gouin, Giovanni Grignani, Rick L. Haas, A.B. Hassan, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Alessandro Gronchi, Silvia Stacchiotti - Annals of Oncology 2021 被引用: 563

  8. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    著者: Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan - The Lancet Oncology 2016 被引用: 541

  9. Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

    著者: Leo Kager, A. Zoubek, Ulrike Pötschger, Ulrike Kastner, Silke Flege, Beate Kempf‐Bielack, D. Branscheid, R. Kotz, M. Salzer‐Kuntschik, Winfried Winkelmann, Gernot Jundt, H. Kabisch, Peter Reichardt, Heribert Jürgens, Helmut Gadner, Stefan Bielack - Journal of Clinical Oncology 2003 被引用: 957

  10. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Paolo G. Casali, N. Abecassis, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, S. Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 751

  11. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    著者: George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, Jean‐Yves Blay, Piotr Rutkowski, Hans Gelderblom, Peter Hohenberger, Michael Leahy, Margaret von Mehren, Heikki Joensuu, Giuseppe Badalamenti, Martin E. Blackstein, Axel Le Cesne, Patrick Schöffski, Robert G. Maki, Sebastian Bauer, Binh Bui Nguyen, Jianming Xu, Toshirou Nishida, John Chung, Christian Kappeler, Iris Kuss, Dirk Laurent, Paolo G. Casali - The Lancet 2012 被引用: 1,401

  12. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Paolo G. Casali, Stefan Bielack, N. Abecassis, Hannu T. Aro, Sebastian Bauer, R. Biagini, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Bernadette Brennan, Thomas Brodowicz, J.M. Broto, Laurence Brugières, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Catharina Dhooge, Mikael Eriksson, Franca Fagioli, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Nathalie Gaspar, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 641

  13. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    著者: Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan, Neyssa Marina, Gordana Jovic, Jane Hook, Mark Krailo, Mark C. Gebhardt, Zsuzsanna Pápai, James S. Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen M. Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul A. Meyers, Richard Görlick, Rein hard Windhager, K. Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula J. Schomberg, Per‐Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerß, Trude Butterfaß‐Bahloul, Carol D. Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark L. Bernstein - Journal of Clinical Oncology 2015 被引用: 421

  14. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren - The Lancet Oncology 2020 被引用: 407

  15. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

    著者: Ralf‐Dieter Hofheinz, Kirsten Merx, Georg Martin Haag, Christoph Springfeld, Thomas J. Ettrich, K Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Margareta Siegler, Matthias P. Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf O. Bechstein, Peter Reichardt, H. Zwenneke Flach, Timo Gaiser, A. Battmann, Fuat Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten Oliver Goetze, Salah‐Eddin Al‐Batran - Journal of Clinical Oncology 2022 被引用: 91

  16. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

    著者: Rolf D. Issels, Lars H. Lindner, Jaap Verweij, Rüdiger Wessalowski, Peter Reichardt, Peter Wust, Pirus Ghadjar, Peter Hohenberger, Martin K. Angele, Christoph Salat, Željko Vujašković, Soeren Daugaard, Olav Mella, Ulrich Mansmann, Hans Roland Dürr, Thomas Knösel, Sultan Abdel-Rahman, M. Schmidt, Wolfgang Hiddemann, Karl‐Walter Jauch, Claus Belka, Alessandro Gronchi - JAMA Oncology 2018 被引用: 322

  17. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke

    著者: Jens Neumann, Monika Riek‐Burchardt, Josephine Herz, Thorsten R. Doeppner, Rebecca König, Heiko Hütten, Eloho Etemire, Linda Männ, Anika Klingberg, Thomas Fischer, Michael Görtler, Hans‐Jochen Heinze, Peter Reichardt, Burkhart Schraven, Dirk M. Hermann, Klaus G. Reymann, Matthias Gunzer - Acta Neuropathologica 2014 被引用: 275

  18. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

    著者: Silvia Stacchiotti, Aisha Miah, Anna Maria Frezza, Christina Messiou, Carlo Morosi, Augusto Caraceni, Cristina R. Antonescu, Jyoti Bajpai, Elizabeth H. Baldini, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Thomas Brodowicz, Dario Callegaro, E. De Alava, M. Deoras-Sutliff, Armelle Dufresne, Mikael Eriksson, Costantino Errani, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Christopher D.�M. Fletcher, Xavier García del Muro, Hans Gelderblom, Rebecca A. Gladdy, F. Gouin, Giovanni Grignani, J. Gutkovich, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Paul H. Huang, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Bernd Kasper, Akira Kawai, Axel Le Cesne, Franel Le Grange, Andreas Leithner, Hugh Leonard, A. Lopez Pousa, Javier Martín‐Broto, Ofer Merimsky, Priscilla Merriam, Rosalba Miceli, Olivier Mir, Michele Molinari, Michael Montemurro, Graziano Oldani, Emanuela Palmerini, Maria A. Pantaleo, S. Patel, Sophie Piperno‐Neumann, Chandrajit P. Raut, Vinod Ravi, Albiruni R. Abdul Razak, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Gonzalo Sapisochín, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, William D. Tap, Annalisa Trama, Andrew Tweddle, Winette T.A. van der Graaf, Michiel A. J. van de Sande, Winan J. van Houdt, G. van Oortmerssen, Andrew J. Wagner, Markus Wartenberg, Jayne Wood, Nadia Zaffaroni, Camilla Zimmermann, Paolo G. Casali, Angelo Paolo Dei Tos, Alessandro Gronchi - ESMO Open 2021 被引用: 183

  19. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

    著者: Penella J. Woll, Peter Reichardt, Axel Le Cesne, Sylvie Bonvalot, Alberto Azzarelli, Harald J. Hoekstra, Michael Leahy, Frits van Coevorden, Jaap Verweij, Pancras C.W. Hogendoorn, M. Ouali, Sandrine Marréaud, Vivien Bramwell, Peter Hohenberger - The Lancet Oncology 2012 被引用: 588

  20. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

    著者: Peter Thuss‐Patience, Albrecht Kretzschmar, Dmitry Bichev, T. Deist, Axel Hinke, Kirstin Breithaupt, Yasemin Doğan, Bernhard Gebauer, Guido Schumacher, Peter Reichardt - European Journal of Cancer 2011 被引用: 615

  21. Risk–Benefit of Dexrazoxane for Preventing Anthracycline-Related Cardiotoxicity: Re-Evaluating the European Labeling

    著者: Peter Reichardt, Marie‐Dominique Tabone, Jaume Mora, Bruce Morland, Robin L. Jones - Future Oncology 2018 被引用: 155

  22. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study

    著者: Sant P. Chawla, Jean‐Yves Blay, Piotr Rutkowski, Axel Le Cesne, Peter Reichardt, Hans Gelderblom, R. J. Grimer, Edwin Choy, Keith M. Skubitz, Leanne L. Seeger, Scott M. Schuetze, Robert M. Henshaw, Tian Dai, Danielle Jandial, Emanuela Palmerini - The Lancet Oncology 2019 被引用: 253

  23. Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

    著者: Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Peter Reichardt, Werner Hohenberger, Claus Ferdinand Eisenberger, Cornelie Haag, Murielle Mauer, Baktiar Hasan, John J. Welch, Katja Ott, Arnulf H. Hoelscher, Paul M. Schneider, Wolf O. Bechstein, H. Wilke, Manfred P. Lutz, Bernard Nordlinger, Eric Van Cutsem, Jörg R. Siewert, Peter M. Schlag - Journal of Clinical Oncology 2010 被引用: 714

  24. One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor

    著者: Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, J. Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah‐Eddin Al‐Batran, M. Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo‐Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari, Mika Leinonen, Thor Alvegård, Peter Reichardt - JAMA 2012 被引用: 969